Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study
Peep Laanmets,
Martijn Meuwissen,
Niels van Royen,
Robert-Jan van Geuns,
Cyril Camaro,
Steven Teerenstra,
Saman Rasoul,
Erik Lipsic,
Rohit M Oemrawsingh,
Peter Damman,
Jan-Quinten Mol,
Anouar Belkacemi,
Rick HJA Volleberg,
Alexey V Protopopov,
Oleg V Krestyaninov,
Robert Dennert,
Jan-Peter van Kuijk,
Karin Arkenbout,
Dirk J van der Heijden,
Maarten AH van Leeuwen
Affiliations
Peep Laanmets
18 North Estonia Medical Centre Foundation, Tallinn, Estonia
Martijn Meuwissen
Department of Cardiology, Amphia Hospital, Breda, The Netherlands
Niels van Royen
Department of Cardiology, Radboudumc, Nijmegen, The Netherlands
Robert-Jan van Geuns
Cardiology, Radboudumc, Nijmegen, The Netherlands
Cyril Camaro
Department of Cardiology, Radboudumc, Nijmegen, The Netherlands
Steven Teerenstra
3 Radboud Institute for Health Sciences, Department for Health Evidence, group Biostatistics, Radboudumc, Nijmegen, Gelderland, The Netherlands
Saman Rasoul
Department of Cardiology, Maastricht Universitair Medisch Centrum+, Maastricht, The Netherlands
Erik Lipsic
Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands
Rohit M Oemrawsingh
Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
Peter Damman
Cardiology, Radboudumc, Nijmegen, Gelderland, The Netherlands
Jan-Quinten Mol
Department of Cardiology, Radboudumc, Nijmegen, The Netherlands
Anouar Belkacemi
Department of Cardiology, Isala Hospitals, Zwolle, The Netherlands
Rick HJA Volleberg
Department of Cardiology, Radboudumc, Nijmegen, The Netherlands
Alexey V Protopopov
Cardiovascular Center, Regional Clinical Hospital, Krasnoyarsk, Russian Federation
Oleg V Krestyaninov
Department of Cardiology, Meshalkin National Medical Research Center, Novosibirsk, Russian Federation
Robert Dennert
Department of Cardiology, Dr Horacio E Oduber Hospital, Oranjestad, Aruba
Jan-Peter van Kuijk
Department of Cardiology, Sint Antonius Hospital, Nieuwegein, The Netherlands
Karin Arkenbout
Department of Cardiology, Tergooi Hospitals, Blaricum, The Netherlands
Dirk J van der Heijden
Department of Cardiology, Haaglanden Medical Center, Den Haag, The Netherlands
Maarten AH van Leeuwen
Department of Cardiology, Isala Hospitals, Zwolle, The Netherlands
Introduction In patients with myocardial infarction, the decision to treat a nonculprit lesion is generally based on its physiological significance. However, deferral of revascularisation based on nonischaemic fractional flow reserve (FFR) values in these patients results in less favourable outcomes compared with patients with stable coronary artery disease, potentially caused by vulnerable nonculprit lesions. Intravascular optical coherence tomography (OCT) imaging allows for in vivo morphological assessment of plaque ‘vulnerability’ and might aid in the detection of FFR-negative lesions at high risk for recurrent events.Methods and analysis The PECTUS-obs study is an international multicentre prospective observational study that aims to relate OCT-derived vulnerable plaque characteristics of nonflow limiting, nonculprit lesions to clinical outcome in patients with myocardial infarction. A total of 438 patients presenting with myocardial infarction (ST-elevation myocardial infarction and non-ST-elevation myocardial infarction) will undergo OCT-imaging of any FFR-negative nonculprit lesion for detection of plaque vulnerability. The primary study endpoint is a composite of major adverse cardiovascular events (all-cause mortality, nonfatal myocardial infarction or unplanned revascularisation) at 2-year follow-up. Secondary endpoints will be the same composite at 1-year and 5-year follow-up, target vessel failure, target vessel revascularisation, target lesion failure and target lesion revascularisation.Ethics and dissemination This study has been approved by the Medical Ethics Committee of the region Arnhem-Nijmegen. The results of this study will be disseminated in a main paper and additional papers with subgroup analyses.Trial registration number NCT03857971.